Stock NEOSTEM INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar NeoStem Inc Nasdaq

Equities

US6406504042

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for NeoStem Inc
Apr. 09 Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma CI
Mar. 21 Sector Update: Health Care Stocks Higher in Late Afternoon Trading MT

Chart calendar NeoStem Inc

da45.oyun-Qz2dSFUB8Z1NdQDU7AdfY7AJ4agqJYg8sUQEj0.knLKl2umMVUCVfcMYaNrJIhzHtr3Q-_N2fFJxYJpfArnUpesYbg3cBBRqQ~a24ff0f1d74a5d6fc8f2bbfa53a7b040

Upcoming events on NeoStem Inc

2024-04-23 11:30 am Immuno Oncology Europe Summit
2024-05-06 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on NeoStem Inc

2024-04-17 01:30 pm Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-04-10 12:00 pm FORCE Family Office Healthcare Conference
2024-04-09 10:00 am LD Micro Invitational Conference
2024-03-07 10:30 am OTC Markets Life Science Investor Forum
2024-02-29 04:30 pm Q4 2023 Earnings Call
2024-02-29 04:05 pm Q4 2023 Earnings Release
2024-02-26 11:15 am BIO CEO & Investor Conference
2024-01-24 09:00 am Sequire Investor Summit
2024-01-16 FORCE Family Office Healthcare Conference
2023-12-04 10:00 am Noble Capital Markets Emerging Growth Equity Conference
2023-11-29 09:00 pm GCFF Healthcare Investment Conference
2023-11-13 Jefferies London Healthcare Conference
2023-11-13 09:30 am LSX Inv€$tival Showcase
2023-11-09 12:00 am FORCE Family Office Healthcare Conference
2023-11-02 04:30 pm Q3 2023 Earnings Call
2023-11-02 04:05 pm Q3 2023 Earnings Release
2023-10-05 10:00 am Bio Future Conference
2023-10-03 10:15 am Bio Century BayHelix East West Biopharma Summit
2023-09-27 08:15 am InfoSec World Conference
2023-09-14 11:00 am LSX World Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-19,1
-19,3
1.13%		-29,0
-30,4
4.62%		-57,5
-59,3
2.98%		-25,5
-27,6
7.54%
-20,4

EBIT
Million USD		Released
Forecast
Spread 		-20,1
-19,7
-1.99%		-19,1
-18,4
-3.8%		-29,1
-30,5
4.7%		-57,6
-43,7
-31.75%		-25,7
-27,2
5.34%
-28,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-19,4
-19,0
-1.9%		-19,0
-18,3
-4.04%		-29,0
-30,4
4.68%		-56,7
-58,8
3.56%		-23,2
-24,7
6.33%
-25,9

Net income
Million USD		Released
Forecast
Spread 		-19,4
-18,9
-2.44%		-8,15
-12,9
36.7%		-27,5
-29,6
7.34%		-54,2
-56,3
3.69%		-20,8
-23,6
11.65%
-25,9

EPS
USD		Released
Forecast
Spread 		-28,2
-27,4
-2.73%		-7,95
-12,2
34.97%		-7,50
-8,25
9.09%		-10,5
-10,9
3.86%		-2,58
-2,91
11.34%
-3,08

Announcement Date05/03/2025/02/2122/03/2230/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread 		-6,84
-8,20
16.57%		-6,61
-7,00
5.53%		-6,71
-7,60
11.67%		-7,32
-7,10
-3.08%		-6,49
-8,30
21.76%		-6,80
-6,60
-2.97%		-6,83
-7,10
3.83%		-5,92
-7,90
25.1%		-5,98
-8,00
25.28%
-6,40


-6,80


-7,20


-8,40

EBIT
Million USD		Released
Forecast
Spread 		-6,85
-8,36
18.09%		-6,62
-7,19
7.94%		-6,72
-6,85
1.91%		-7,33
-6,95
-5.39%		-6,54
-7,47
12.48%


-6,88
-7,17
4.05%		-5,96
-7,89
24.42%		-6,03
-7,52
19.85%
-6,91


-6,91


-6,91


-6,91

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,79
-8,21
17.21%		-6,71
-7,08
5.24%		-6,63
-7,19
7.9%		-37,4
-6,98
-435.61%		-5,99
-8,10
26.04%		-6,19
-6,60
6.26%		-6,36
-6,79
6.38%		-5,26
-7,57
30.46%		-5,37
-7,02
23.59%
-6,06


-6,26


-6,46


-7,11

Net income
Million USD		Released
Forecast
Spread 		-6,79
-8,96
24.14%		-4,23
-7,08
40.28%		-6,63
-7,19
7.9%		-37,4
-6,98
-435.61%		-5,99
-8,10
26.04%		-6,19
-6,60
6.26%		-4,03
-5,69
29.23%		-5,26
-7,57
30.46%		-5,37
-7,02
23.59%
-6,06


-6,26


-6,46


-7,11

EPS
USD		Released
Forecast
Spread 		-1,65
-2,25
26.67%		-1,05
-1,73
39.13%		-1,65
-1,73
4.35%		-7,88
-1,28
-518.04%		-0,76
-1,02
25.49%		-0,77
-0,81
4.94%		-0,50
-0,70
28.57%		-0,65
-0,93
30.11%		-0,66
-0,86
22.81%
-0,73


-0,75


-0,77


-0,84

Announcement Date22/03/2205/05/2204/08/2210/11/2230/03/2309/05/2314/08/2302/11/2329/02/24----

Upcoming sector events for NeoStem Inc

2024-04-21 MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-22 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release
2024-04-23 SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
2024-04-23 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
2024-04-23 CUREVAC N.V.: Q4 2023 Earnings Release
2024-04-23 ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release
2024-04-23 EVOTEC SE: Q4 2023 Earnings Release
2024-04-24 01:45 am ADDLIFE AB: Q1 2024 Earnings Release
More events

Past sector events for NeoStem Inc

2024-04-17 HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release
2024-04-17 02:07 am TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report
2024-04-10 04:10 pm PHARVARIS N.V.: Q4 2023 Earnings Release
2024-04-10 01:22 am POLARIS GROUP: March 2024 Sales and Revenue Release
2024-04-02 02:30 am ABIVAX: Q4 2023 Earnings Release
2024-04-01 09:00 am BIOMEA FUSION, INC.: Q4 2023 Earnings Release
2024-03-28 10:42 pm ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release
2024-03-28 04:28 pm CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release
2024-03-28 04:05 pm ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release
2024-03-28 07:10 am HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. LSTA Stock
  4. Stock
  5. Calendar NeoStem Inc